Indatech
Chauvin Arnoux Group
Information
Indatech, a partner in the ClimbIN project
6 March 2025
As part of the Grand Défi Biomédicaments initiative, France has invested several hundred million euros in a call for proposals on the theme “New Biotherapies and Production Tools.” The ClimbIN project is among the first winners, and Indatech is a partner.
As a co-founder of Indatech, he explains the project’s goals, the context, and the technologies being developed in an interview you can watch now!
Interview with Fabien Chauchard!
Indatech aims to develop, with the help of all partner members of the ClimbIN consortium, an innovative monitoring solution capable of simultaneously monitoring more than a dozen critical parameters on-site and in real time.
See the video
> To understand the objectives of the ClimbIN project.
Check out our scientific fact sheet
Consortium members:
- Rabelais University in Tours is the lead partner
- NMNS Laboratories (Nano-Drugs and Nano-Probes)
- Bio3 in Tours
- The LRGP (Reactions and Process Engineering Laboratory) at the University of Nancy
- The IMT Group
- Indatech
- Ondalys
- The Servier pharmaceutical group.
Coordination among the various consortium members will enable the ClimbIN project to cover all phases of development: academic laboratories, R&D, pilot, and industrial.
The Benefits of Our Raman and Multi-Angle Spectroscopy Solutions
In his testimonial, Fabien Chauchard explains how our spectroscopy solutions can help improve bioproduction.
The sensors we’ve developed will enable in-line measurement directly inside the bioreactor, without the need for sampling and in real time. This monitoring will work equally well with glass, stainless steel, or single-use plastic containers. Monitored in this way, bioprocesses will be optimized to achieve the highest yield and minimize losses—a prerequisite for making biotherapeutics more accessible.
